Introduction
Hepatocyte growth factor/scatter factor (HGF/SF) is a mesenchymally derived factor with pleiotrophic activities on epithelial cells; it stimulates scattering, motility and invasiveness of epithelial cells, and induces branching tubulogenesis of lung, breast and kidney epithelium cultured within matrix (for reviews see Bardelli et al., 1997b; Vande Woude et al., 1997) . In vivo, HGF/SF is a potent angiogenic factor (Maggiora et al., 1997) and is crucial for development, as demonstrated by the embryonic lethality of mice lacking the gene encoding HGF/SF (Uehara et al., 1995) . A high anity receptor for HGF/SF has been identi®ed as the Met receptor tyrosine kinase (Naldini et al., 1991a,b) , and by using receptor chimeras, the role of Met in mediating the pleiotrophic biological responses of HGF/SF in epithelial cells has been established (Zhu et al., 1994b) . In addition to its role in controlling biological responses in normal cells, Met has been implicated in contributing to malignant transformation. Thus, ampli®cation and overexpression of the Met gene is a frequent event in many human tumors (see references in Bardelli et al., 1997b; . Further, missense mutations that deregulate the enzymatic activity of Met have been found to be associated with human papillary renal carcinomas . Consistent with these ®ndings, Met was originally identi®ed as an oncogene, Tpr/Met (Dean et al., 1987; Gonzatti-Haces et al., 1988) , which is expressed in various human tumor cell lines (Soman et al., 1990) . The chimeric Tpr/Met gene, which is formed following fusion of the sequences encoding the amino-terminus of the Tpr gene and the cytoplasmic domain of the Met receptor tyrosine kinase (Dean et al., 1987) , codes for a constitutively activated Met kinase possessing transforming activity (Rodrigues and Park, 1993) .
Activation of Met promotes transphosphorylation of several tyrosine residues that regulate the signaling function of Met (Longati et al., 1994; Rodrigues and Park, 1994) . Thus, two phosphotyrosine residues (tyrosine-1349 and tyrosine-1356) in the`multi-functional docking site' of the Met receptor serve as binding sites for multiple signaling molecules (Bardelli et al., 1997b) . Tyrosine-1356, which is crucial for Metinduced scattering, motility and tubulogenesis formation (Ponzetto et al., 1996) , forms a multisubstrate docking site for the Grb2 adapter protein, the p85 subunit of PI 3-kinase, phospholipase C-g and protein tyrosine phosphatase SHP2 Ponzetto et al., 1994; Zhu et al., 1994a) . Together with tyrosine-1349, tyrosine-1356 is required for the association of the Shc adapter protein with Met (Pelicci et al., 1995) . In the case of Tpr/Met, it has been shown that a single carboxy-terminal tyrosine residue, tyrosine-489, is essential for the association of Tpr/ Met with the various SH2-domain containing molecules that bind to the tyrosine-1356 site in the Met receptor (Bardelli et al., 1997a; Fixman et al., 1997 Fixman et al., , 1995 Kamikura et al., 1996) . A Y489F Tpr/Met mutant transforms cells at 20% of the eciency of the wild type Tpr/Met protein , suggesting that signaling complex formation at this site is essential for the oncogenic activity of Tpr/Met.
In addition to the numerous Met-binding SH2-containing molecules, the 110 kDa docking protein Gab1 has emerged as a major signaling protein downstream of Met Weidner et al., 1996) . Gab1, which was originally identi®ed as a Grb2-associated protein, becomes tyrosine phosphorylated in response to a number of cellular stimuli, including Met stimulation (Holgado-Madruga et al., 1996) . Gab1 contains multiple domains capable of mediating protein ± protein interactions, and in addition to Grb2, it binds to several other signaling molecules, such the p85 subunit of PI 3-kinase, phospholipase C-g and SHP2 upon cellular stimulation. It has been shown that Grb2 binds simultaneously via its SH3-domain to Gab1 and via its SH2-domain to Met, suggesting a role for Grb2 in connecting Gab1 to activated Met (Bardelli et al., 1997a; Fixman et al., 1997; Nguyen et al., 1997) . A direct interaction between tyrosine-1349 in the Met receptor (which corresponds to tyrosine-482 in Tpr/Met) and a domain of Gab1 named as Met-binding domain (MBD) has also been identi®ed using the yeast two-hybrid system (Weidner et al., 1996) . Together, these data support a model in which Met signaling could be elicited directly via its interactions with SH2-containing proteins or via the establishment of a Met/(Grb2)/Gab1 complex and the subsequent interaction of Gab1 with additional SH2-containing eector molecules.
Recent ®ndings suggest an important role for Gab1 in Met signaling. Thus, Tpr/Met-mediated cellular transformation correlates with the ability of this oncogene to associate with and phosphorylate Gab1 (Bardelli et al., 1997a; Fixman et al., 1997) . Similar results have been obtained with respect to Met-induced branching morphogenesis (Weidner et al., 1996) . Further, overexpression of a truncated form of Gab1 consisting of the Met-binding domain was shown to strongly impair the response of Met-signals with respect to tubulogenesis (Weidner et al., 1996) . So far, the biochemical signaling events downstream of Gab1 in mediating these or other biological eects are virtually unknown. Among the diverse biochemical pathways triggered by Met is the stimulation of mitogen-activated protein kinases (MAPK), including c-Jun N-terminal kinases (JNK). Importantly, it has been shown that JNK activation is essential for cellular transformation and induction of soft agar growth by Tpr/Met (Rodrigues et al., 1997) . Despite the apparent signi®cance of this signaling pathway, the molecular interactions connecting Met to the JNK cascade are largely unknown (Rodrigues et al., 1997) . Interestingly, expression of another oncogene, v-Crk, was recently demonstrated to transform cells in a JNK-dependent manner (Tanaka et al., 1997) . Recent ®ndings in our laboratory in turn have established that c-Crk, the cellular homologue of v-Crk, is a component in connecting various cellular stimuli to JNK activation (Dol® et al., 1998) . Hence, we set forth to study whether a previously unidenti®ed connection between the Met and the Crk pathways might play a role in Met-induced JNK activation and cellular transformation. We demonstrate here that tyrosine-phosphorylated Gab1 serves as a functional docking site for the SH2-domain of Crk and that Gab1 ± Crk interaction may in turn lead to the stimulation of the JNK pathway by Met kinase activity.
Results
The adapter protein Crk connects Met signaling to the activation of the JNK pathway Previous studies by Rodrigues et al. (1997) have demonstrated a crucial role for JNK activation in cellular transformation by the Tpr/Met oncogene. In addition, the JNK pathway has recently been shown to mediate important cellular functions in response to HGF/SF stimulation in hepatocytes (Auer et al., 1998) . At present, very little is known about the pathways leading to JNK activation downstream of Met. We have recently established a role for the adapter protein Crk in connecting several signaling pathways to the activation of the JNK kinase cascades (Dol® et al., 1998) . Our studies indicate that forms of Crk that harbor loss-of-function mutations in either the SH2 or SH3 domain of Crk act as dominant-negative proteins when ectopically expressed and speci®cally inhibit the activation of the JNK pathway, but not of the parallel Erk MAP kinase pathway, in response to integrinmediated cell adhesion, EGF stimulation and v-Src signaling (Dol® et al., 1998) ; the speci®city of the Crkmutants in inhibiting the Crk-pathway has been well established by other investigators, as well (Klemke et al., 1998; Matsuda et al., 1994 Matsuda et al., , 1992b Tanaka et al., 1995 Tanaka et al., , 1993 . We therefore set forth to investigate whether Crk is a component in the pathway connecting Met to the JNK pathway by using the Crk dominantnegative constructs in transient transfection experiments. As shown in Figure 1a , HGF/SF eciently induced JNK activity in a concentration-dependent manner. The highest HGF/SF concentration tested, 75 ng/ml, resulted in more than nine-fold induction in the JNK kinase activity. This activation was significantly impaired when the dominant ± negative Crk ± SH2 mutant (R38V-mutation) was expressed, suggesting that Crk is a component of the Met ± JNK pathway. To further characterize the role of the adapter protein Crk in Met-dependent activation of the JNK pathway, we performed parallel experiments using an oncogenic version of the Met receptor, Tpr/ Met. Transient expression of Tpr/Met in HeLa cells resulted in a substantial activation of JNK. In accordance with the results obtained with HGF/SF stimulation, expression of the Crk-mutants remarkably impaired the activation of JNK by Tpr/Met ( Figure  1b ). c-Jun transcriptional activation assays con®rmed that Crk is a major component in the JNK pathway induced by the Met kinase. As shown in Figure 1c (upper panel), expression of either the Crk ± SH2 or the Crk ± SH3 (W169L-mutation) mutant constructs resulted in a signi®cant reduction in the Tpr/Met-induced c-Jun transcriptional activity, as assessed by luciferase reporter assay. Identical results were obtained when the JNK pathway was activated by HGF/SF stimulation ( Figure 1c, lower panel) . Expression of wild-type Crk in turn enhanced Met-induced activation of the JNK pathway (not shown). We found that the dominant ± negative Crk-constructs are speci®c inhibitors for the JNK pathway as neither the Crk ± SH2 (Figure 1d ) nor the Crk ± SH3 mutant (data not shown) aected the activation of the parallel Erk kinase by Tpr/Met (Figure 1d) HeLa cells were transfected with plasmids encoding for JNK (JNK with a Flag epitope, M2) alone or together with the cDNA for the Crk ± SH2 mutant (Crk ± R38V). The cells were treated with various concentrations of HGF/SF for 15 min and subjected to immunocomplex kinase assay experiments. Expression levels of endogenous or recombinant proteins were assessed by immunoblotting with speci®c antibodies. The expressed Crk-construct contains an amino-terminal myc-epitope, which results in a mobility shift of the expressed protein on SDS ± PAGE. (b) HeLa cells were transfected with plasmids coding for JNK ± FLAG and wild-type Tpr/Met (WT), kinase-dead mutant of Tpr/Met (KD) or Crk ± SH2 mutant protein. JNK activity was determined by immunocomplex kinase assays. Expression levels of endogenous or recombinant proteins were determined by immunoblotting as above. (c) HeLa cells were transfected with pFR ± Luc and pFA ± c-Jun(1-223)(Gal4 ± c-Jun) together with expression vectors for Crk ± SH2 or Crk ± SH3 (Crk ± W169L) mutants. In the upper panel, the cells were co-transfected with an expression vector for Tpr/ Met WT as indicated. In the lower panel, cells were stimulated with HGF/SF (100 ng/ml) for 7 h prior to analysis. Transcriptional activity of Gal4 ± c-Jun was evaluated using the Luciferase expression as a reporter gene. (d) HeLa cells were transfected with plasmids encoding HA-tagged Erk kinase and wild-type Tpr/Met or Crk ± SH2 mutant proteins as indicated. Erk kinase activity was determined by immunocomplex kinase assays. Expression levels of endogenous or recombinant proteins were determined by immunoblotting with speci®c antibodies. MBP states for myelin basic protein of Crk in a tyrosine phosphorylation-dependent manner in response to various cellular stimuli (Casamassima & Rozengurt, 1997; Ingham et al., 1996; Nojima et al., 1995; Ojaniemi et al., 1997; Petch et al., 1995; Ribon & Saltiel, 1996; Schraw & Richmond, 1995; Vuori & Ruoslahti, 1995) , and we have recently found that the Cas ± Crk interaction is important for JNK activation in response to integrin-mediated cell adhesion (Dol® et al., 1998) . We therefore investigated whether Met kinase activity induces tyrosine phosphorylation of Cas and, as a result, Cas ± Crk interaction. As shown in Figure 2a , no induction in tyrosine phosphorylation of Cas was observed upon stimulation of HeLa cells with HGF/SF for 15 min. As a matter of fact, stimulation of cells with HGF/SF at concentrations above 50 ng/ml resulted in a noticeable tyrosine dephosphorylation of Cas; the same concentration range of HGF/SF eectively activated JNK (Figure 1a) . Similarly, chronic exposure of cells to Met kinase activity through Tpr/Met expression, which results in a robust JNK activation (Figure 1 ), substantially reduced the phosphotyrosine content of Cas ( Figure 2b) . Importantly, the reduced phosphotyrosine content in Cas upon HGF/SF stimulation correlated with a dissociation of the Cas ± Crk protein complex. Thus, when Crk was immunoprecipitated from HeLa cells that were treated with HGF/SF, a reduced amount of Cas was found to be associated with the Crk complex as compared to control cells ( Figure 2c ). In addition, expression of a deletion mutant of Cas that fails to interact with Crk and acts as a dominant ± negative protein by blocking JNK activation in response to integrin ligation (Dol® et al., 1998) did not aect the Met-dependent activation of this MAP kinase pathway (data not shown). Together, these ®ndings indicate that the Cas ± Crk interaction is unlikely to play a role in Metmediated JNK activation. Instead, the data presented here suggest that Met induces disassembly of the Cas ± Crk signaling complex and as a result, additional tyrosine-phosphorylated binding partner(s) for the SH2-domain of Crk may participate in the Met-induced signaling cascade leading to JNK activation.
Crk associates with tyrosine-phosphorylated Gab1 in response to HGF/SF stimulation
In order to identify putative Crk ± SH2-binding proteins that have a role in connecting the Met kinase via Crk to the JNK pathway, we searched for proteins that would become tyrosine-phosphorylated and bind to Crk in HGF/SF-stimulated cells. As shown in Figure 3a , the interaction between Crk and phosphotyrosine-containing protein(s) of 130 kDa in molecular weight was prominent in control cells but declined upon exposure of cells to HGF/SF. Taken into consideration our results described above, Cas is likely to be a major component among these phosphoproteins. On the other hand, HGF/ SF stimulation enhanced the interaction of Crk with phosphotyrosine-containing proteins of 110 kDa in molecular weight (Figure 3a ). Gab1 is a recently identi®ed 110 kDa docking molecule that becomes tyrosine phosphorylated in a Met-dependent fashion and as a result, associates with SH2-domain containing signaling molecules . Indeed, we found that stimulation of cells with HGF/SF readily triggered tyrosine phosphorylation of Gab1 (Figure 3b ), which in turn correlated with an increased Gab1 ± Crk association as indicated by coimmunoprecipitation experiments (Figure 3c ). Importantly, tyrosine phosphorylation of Gab1 by HGF/SF took place in a concentration-dependent manner (Figure 3d ), and correlated very well with the concentration course observed for HGF/SF-induced JNK activation (see Figure 1a ). These data indicate that HGF/SF induces a previously unidenti®ed association between Gab1 and Crk, which may play a role in connecting Met kinase activity to the JNK pathway.
Activation of the JNK pathway by Met requires Met kinase activity and correlates with the establishment of the Met ± Gab1 ± Crk protein complex Two signaling de®cient mutants of the Tpr/Met oncoprotein were generated to characterize the (100 ng/ml) for 15 min were immunoprecipitated with an anti-Crk antibody and the coprecipitation of Cas was analysed by immunoblotting using an anti-Cas antibody (left panel). The total amount of Cas in the cell lysates employed for the analysis was determined by immunoblotting with an anti-Cas antibody (right panel). Control immunoprecipitations were carried out using sepharose-beads coupled to protein A putative role of the Gab1 ± Crk complex in the activation of the JNK pathway by Met kinase in more detail. The Tpr/Met KD-construct contains a lysine-to-alanine mutation in the catalytic domain of the Met kinase that completely abolishes the Met kinase activity, while the Tpr/Met YY-construct contains a dual tyrosine-to-phenylalanine mutation in residues 482 and 489 in a region of Met known as thè multi-functional docking site' (see Introduction). These tyrosine residues are required for the association of Tpr/Met with signaling molecules such as Grb2 and Gab1. Previous reports have demonstrated that both the kinase activity and the integrity of the multifunctional docking site are required for cellular transformation by the Tpr/Met oncogene (Bardelli et al., 1997a; Fixman et al., 1997) . In concordance with these data, we found that JNK kinase activity is enhanced in HeLa cells that were transiently transfected with the wild-type Tpr/Met construct but not with either one of the signaling de®cient mutants (Figures 1b and 4a) . Our subsequent experiments demonstrated that the ability of the various Tpr/Met constructs to activate the JNK pathway correlated with their capacity to associate with Gab1 and to induce tyrosine phosphorylation of Gab1 and Gab1 ± Crk complex formation. As shown in Figure 4b , transient expression of wild-type Tpr/Met in HeLa cells enhanced tyrosine phosphorylation of endogenous Gab1. In contrast, expression of either one of the Tpr/Met mutants had no signi®cant eect on the phosphorylation status of Gab1. Similarly, a tyrosinephosphorylated 110-kDa protein was found to associate with the Tpr/Met wild-type but not with the signaling de®cient Met proteins in immunoprecipitation experiments (Figure 4c, left panel) ; dissociation of the immunoprecipitated Tpr/Met protein complex followed by reimmunoprecipitation using anti-Gab1 antibodies demonstrated that the p 110 kDa protein is Gab1 (Figure 4c, right panel) . Also, only the wild type, but not the mutant forms of Tpr/Met, was found to be in a protein complex with Crk and to induce Gab1 ± Crk association. Thus, when Tpr/Met or Gab1 were immunoprecipitated from HeLa cells that had been transiently transfected with the various Tpr/Met constructs, Crk was found in the immunoprecipitates only from cells that had been transfected with the wildtype, but not with the mutant forms of Tpr/Met (Figure 4d ). Together, these results demonstrate a correlation between Met kinase activity, Gab1 tyrosine phosphorylation, formation of the Met ± Gab1 ± Crk signaling complex and activation of the JNK pathway.
The SH2-domain of Crk interacts directly with tyrosine phosphorylated Gab1 in yeast Based on the results above, we hypothesized that Gab1 functions as a tyrosine-phosphorylated docking molecule that directly interacts with the SH2-domain of Crk in response to Met kinase activity, thereby connecting Met through Crk to the downstream JNK signaling pathway. The possibility of a direct protein ± protein interaction between Gab1 and Crk was further suggested by the presence of multiple potential tyrosine phosphorylation sites in Gab1 that conform to the YDXP-consensus sequence for the binding of the SH2-domain of Crk. We therefore set forth to determine whether Gab1 associates directly with the SH2-domain of Crk in a tyrosine phosphorylationdependent manner. We employed a modi®ed yeast twohybrid analysis using the SH2 domain of Crk (Crk ± SH2) and the region of Gab1 (Gab1 ± SD) that contains the YDXP-sequences. To overcome the limitation that tyrosine phosphorylation of cytosolic proteins does not take place in Saccharomyces cerevisae, we introduced an active tyrosine kinase, cSrc (Y416F, Y527F) as a third component to the yeast two-hybrid screen. As demonstrated in Figure 5 , coexpression of Gab1 ± SD and Crk ± SH2 induced bgalactosidase activity in yeast only when the active cSrc mutant was coexpressed. We determined by immunoblotting that tyrosine phosphorylation of the LexA/Gab1 ± SD fusion protein was detectable solely in cells expressing the exogenous tyrosine kinase (data not shown). Controls using irrelevant peptides con®rmed that transactivation of the reporter b-galactosidase gene was speci®c for the Gab1 ± SD/Crk ± SH2 interaction ( Figure 5 ). Hence, these ®ndings demonstrate that tyrosine phosphorylation of Gab1 results in a direct interaction between Gab1 and the SH2-domain of Crk.
JNK activation by HGF/SF is enhanced by Gab1 expression and blocked by the expression of the Met ± Binding ± Domain of Gab1
After having established a correlation between Met ± Gab1 ± Crk complex formation and JNK activation, several studies were carried out to investigate the potential functional signi®cance of Gab1 in Metmediated JNK activation. Gab1 was coexpressed in cells with Tpr/Met wild-type and the activation of the JNK pathway assessed by Gal4 ± c-Jun transcriptional regulation of luciferase gene expression. As shown in Figure 6a , expression of Gab1 signi®cantly enhanced the activation of the JNK pathway by the wild-type Tpr/Met, and this enhancement in turn was strongly inhibited by the dominant ± negative Crk ± SH2 construct. Ectopic expression of Gab1 alone did not enhance the JNK pathway (Figure 6a ), a result that agrees with our ®nding that recombinant Gab1 does not become tyrosine-phosphorylated nor associate with Crk in the absence of stimulation (data not shown). The role of Gab1 was further studied by in vitro kinase reactions using transiently transfected HeLa cells that were stimulated with HGF/SF. As shown in Figure 6b , expression of Gab1 markedly increased HGF/SFinduced JNK kinase activity. Further, we expressed a fragment of Gab1 that comprises the Met-binding domain of Gab1 (MBD). The Met-binding domain of Gab1 has been reported to directly associate with the Met kinase and, when overexpressed as a fragment, to compete for the binding of Met with the endogenous Gab1 and eectively function as a dominant-negative construct for Met ± Gab1 signaling (Weidner et al., 1996) . Importantly, expression of the Met-binding were used to immunoprecipitate Tpr/Met or Gab1 using speci®c antibodies and assayed for the coimmunoprecipitation of Crk by immunoblotting with an anti-Crk antibody. The presence of equal amounts of Crk in all protein lysates was determined by analysing aliquots of total protein lysates in the same conditions. Control immunoprecipitations were carried out using sepharose beads coupled to protein A domain of Gab1 completely abolished JNK activation by HGF/SF (Figure 6b ). Taken together, these data suggest a functional role for Gab1 in the Met-mediated JNK activation upstream of the adapter protein Crk.
Met activates the MMP-1 promoter via an AP-1 enhancer element: blockage by dominant ± negative Crk and enhancement by Gab1
In addition to anchorage ± independency of growth (see Introduction), Met activation has been shown to contribute to another hallmark phenotype of malignancy, namely cell invasion of the extracellular matrix (Bardelli et al., 1997b; Maggiora et al., 1997) . The latter phenotype suggests that proteolytic enzymes, such as matrix metalloproteinases (MMPs), are likely to be induced downstream of Met activation. To study this possibility, we utilized a semi-quantitative RT ± PCR analysis to study possible activation of MMP-1 gene transcription in response to Met signaling. Indeed, we found that activation of Met by HGF/SF treatment in carcinoma cell line A549 signi®cantly enhances basal MMP-1 mRNA expression levels. As shown in Figure  7a , PCR analysis of cDNAs prepared from A549 cells Figure 5 Tyrosine phosphorylation of Gab1 induces its interaction with the SH2 domain of Crk in yeast two-hybrid system. (a) Colony-life b-galactosidase assay of yeast growth in restrictive media lacking tryptophan, leucine and histidine. The assay was performed using L40 yeast strains that were transformed with the plasmids indicated in (b). (b) Liquid assays for b-galactosidase activity. The L40 yeast strain was cotransformed with LexA DNA-binding domain fusion plasmids (pBTM116) expressing either the SH2-domain of Crk alone (Crk ± SH2) or in combination with an active Src tyrosine kinase mutant (Src ± Crk ± SH2), and negative-control protein (Cas ± SR), together with either the pVP16 plasmids including the cDNA for a partial sequence of Gab1 (Gab1 ± SD, see methods) or a negative-control protein (14-3-3). Three independent transformations per sample were performed and the results are shown as average activity units with the standard deviation Figure 6 Gab1 expression enhances the activation of the JNK pathway by Met in a Crk-dependent manner. (a) HeLa cells were transfected with the plasmids pFR ± Luc, pFA ± c-Jun(1-223) (Gal4 ± c-Jun) and expression vectors for wild-type Tpr/Met, full-length Gab1, and Crk ± SH2 mutant (Crk ± R38V) protein as indicated. Gal4 ± c-Jun transcriptional activity was determined by measuring the expression levels of the luciferase reporter gene. (b) HeLa cells were transfected with plasmids encoding for JNK (Flag-tagged), full-length Gab1 (HA-tagged), and the Met Binding Domain of Gab1 (Gab1 ± MBD) as indicated in the ®gure. Lysates from cells that were treated or not with HGF/SF (25 ng/ml) were subjected to immunocomplex JNK kinase assay. The expression of endogenous or recombinant proteins was determined by immunoblotting using speci®c antibodies that were treated or not with 40 ng/ml of HGF/SF yielded a band (529 bp) that corresponds to a fragment of MMP-1 mRNA, and treatment with HGF/SF augmented signi®cantly the amount of MMP-1 expression levels in the cells. Similarly, when HeLa cells ± which display undetectable basal expression levels for MMP-1 mRNA ± were transfected with an active Met kinase (Tpr/Met), the transcription of the MMP-1 gene was clearly enhanced (Figure 7a ). These data demonstrate that Met kinase activity promotes the expression of MMP-1 in cells, and suggest that this response might be relevant for Met-mediated enhanced metastatic phenotypes of tumors.
Several human MMP gene promoters contain binding sites for the Fos/Jun-containing AP-1 complex among their regulatory elements and notably, the AP-1 complex is known to be directly regulated by members of the MAP family kinases (Crawford and Matrisian, 1996; Karin et al., 1997) . We therefore decided to investigate whether Met kinase activity regulates the transactivation of the MMP-1 promoter, and if so, whether the JNK pathway is of importance in this response. The various MMP-1/luciferase reporter gene promoter constructs used in this study are schematically depicted in Figure 7b . As shown also in Figure  7b (Figure 7b, left middle panel) . Signi®cantly, expression of the dominant ± negative Crk ± SH2 construct completely blocked transcriptional activity of the full-length and truncated MMP-1 promoters in response to Tpr/Met and Gab1 expression (Figure 7b , right middle panel). Taken together, our results suggest that the pathway linking Met to Gab1 ± Crk and JNK activation is an important step in the regulation of the MMP-1 promoter transcriptional activity.
Discussion
Germ-line and somatic mutations of the Met tyrosine kinase receptor have been identi®ed in human papillary carcinomas, which create a constitutive activated kinase with the ability to induce cell growth and metastasis Schmidt et al., 1997 Schmidt et al., , 1998 . These proteins, similarly to the previously identi®ed Met oncogene Tpr/Met and the ligand activated wild-type Met receptor, signal through two phosphorylated tyrosines located in a region named as multi-functional docking site in the Met molecule (Bardelli et al., 1998) . This region binds to a number of dierent cytoplasmic signaling eectors thereby Figure 7 Met kinase activity enhances transcriptional activity of the MMP-1 gene by acting on an AP1 enhancer element that is controlled by JNK kinase activity. (a) Upper left panel, A549 cells were grown to 80% con¯uency and treated or not with 40 ng/ml of HGF/SF for 6 h at 378C in serum free media. Total RNA was prepared from cell cultures and used to synthesize cDNA using random hexamers and oligo-dT to prime the reaction. MMP-1 mRNA expression levels was assessed by PCR using sequence speci®c oligonucleotides in cDNA aliquots that were previously normalized during the linear range of the PCR ampli®cation for the expression of the house-keeping gene b-actin. Lower left panel shows a control PCR ampli®cation performed in parallel with primers for b-actin. Upper right panel, HeLa cells were transiently transfected with an empty vector or a vector encoding the wildtype Tpr/Met and total RNA was extracted and analyzed as indicated above two days after transfection. The cells were grown in the presence of 10% fetal calf serum during the course of the experiment. Control b-actin RT-PCR amplication results are shown in the lower right panel. PCR ampli®cation products, demonstrating that neither plasmid nor genomic DNA contamination interfered with the assay (not shown). (b) COS-7 cells were transfected with reporter plasmids in which the expression of the reporter luciferase gene is controlled by MMP-1 promoter sequences. The plasmids include a full-length MMP-1 promoter (MMP-1-Luc, solid black bars), and two sequential truncations (MMP-1(773)-Luc, dashed bars, and MMP-1(763)-Luc, empty bars). The cells were also co-transfected with combinations of expression plasmids for the wild-type Tpr/Met, full-length Gab1 and the mutant Crk-SH2 protein (Crk-R38V). The transcriptional activity of the MMP-1 promoters was determined by assessing the luciferase activity of the samples activating downstream biochemical pathways that elicit various biological eects including cell transformation. However, the precise function of the various interactions on speci®c signaling pathways or biological responses remains elusive. Recent studies by Rodrigues et al. (1997) have demonstrated that activation of the JNK pathway is essential for cell transformation by Tpr/Met; by implication, this pathway may be of importance in the signaling events downstream of the wild-type Met receptor and the human Met oncogenes linked to renal papillary carcinoma. We demonstrate here that the multi-functional docking site of Met is indeed required for JNK activation. Our results further suggest a linear cascade of events where the multifunctional docking site of Met interacts with Gab1 and induces the phosphorylation of tyrosine residues that bind to the SH2 domain of the adapter protein Crk, which in turn is an essential step for the activation of the JNK pathway.
Crk is an adapter protein that consists of an SH2-and SH3-domains (Reichman et al., 1992) ; the SH2-domain of Crk is known to bind to tyrosinephosphorylated proteins containing the motif Y ± D ± X ± P while the amino-terminal SH3-domain recognizes proline-rich motifs in various cytoplasmic proteins (Feller et al., 1995) . We found here that expression of loss-of-function mutants of Crk in which the SH2 or the amino-terminal SH3 domains have been inactivated severely impairs the activation of JNK by the Met kinase. These dominant ± negative forms of Crk did not have any eect on Met-induced activation of Erk, demonstrating for speci®city for the JNK pathway. These results suggest that Crk serves as a linker connecting upstream and downstream signaling molecules in the pathway that leads to JNK activation by Met. Recent research in our laboratory has shown that the adapter Crk participates in the JNK pathway elicited by other stimuli, including integrin-mediated cell adhesion (Dol® et al., 1998) . In this signaling cascade, integrin ligand-binding induces tyrosine phosphorylation of the docking protein p130
Cas (Cas) and the formation of the Cas ± Crk complex which in turn activates the JNK pathway. Of note, tyrosine phosphorylation of Cas has been previously linked to oncogenesis (Sakai et al., 1994) , and cells derived from Cas null mice are resistant to transformation by such potent oncogenes as v-Src (Honda et al., 1998) . In addition to having a signi®cant role in cellular transformation, the interaction between Cas ± Crk has been linked to increased cell motility (Klemke et al., 1998) . Since Met kinase activity is a potent inducer of transformation and metastasis, we explored the possibility that Met activation would utilize the Cas ± Crk complex to connect to the JNK pathway. Somewhat surprisingly, we found that Tpr/Met expression and HGF/SF stimulation result in dephosphorylation of Cas and dissociation of the Cas ± Crk complex. These results are not unprecedented, however, as dephosphorylation of Cas and shuttling of Crk between diverse docking proteins has also been demonstrated for epidermal growth factor and insulin signaling; treatment of cells with these growth factors results in dissociation of the Cas ± Crk complex and Crk association with the docking proteins p120Cbl and insulin receptor substrate-1, respectively (Khwaja et al., 1996; Sorokin and Reed, 1998).
Our results identify Gab1 as a novel Crk-binding protein that serves as the docking site for Crk in the Met pathway. Thus, HGF/SF stimulation or Tpr/Met expression induces the tyrosine phosphorylation of Gab1 and its concomitant interaction with Crk. The primary structure of Gab1 displays a central core of multiple sequences, which conform to the consensus site for binding to the Crk ± SH2 domain. We found that this region of Gab1 interacts with the Crk SH2-domain in a tyrosine phosphorylation-dependent manner in yeast. In addition, we also found that Gab1 becomes associated with isolated Crk SH2-domains in`pull-down' experiments only in cells that had been stimulated with HGF/SF (data not shown).
Together, these ®ndings demonstrate that the Gab1 ± Crk association in mammalian cells harboring active Met most likely is direct and mediated via the SH2-domain of Crk.
Our results suggest that the Gab1 ± Crk interaction may function as a molecular switch to trigger the JNK pathway upon Met kinase activity. First, we found that both Gab1 ± Crk interaction and JNK activation are fully dependent on the kinase activity of Met and on the integrity of the multi-functional docking site in Met. Thus, expression of the wild-type form of Tpr/ Met induces the association of the Gab1 ± Crk complex and JNK activation, whereas mutant forms of Tpr/Met in which kinase activity or the multi-functional docking site have been disrupted fail to do so. Furthermore, a similar correlation exists following HGF/SF stimulation: concentrations of HGF/SF that eectively stimulate Gab1 phosphorylation and Gab1 ± Crk interaction are eective in the activation of the JNK pathway. Second, Gab1 is a positive regulator of the JNK activation downstream of Met, as overexpression of wild-type Gab1 results in augmentation of HGF/SF and Tpr/Met induced JNK kinase activity and c-Jun transcriptional activation. Importantly, this enhancement was blocked by dominant-negative forms of Crk, demonstrating that Gab1 and Crk reside in a linear pathway downstream of Met. Third, expression of a fragment of Gab1 that directly binds to the Met receptor (MBD-fragment) eciently blocks HGF/SFinduced JNK activation. This region of Gab1 has been previously shown to speci®cally associate with Met and when expressed as a single domain in mammalian cells to eliminate biological responses to HGF/SF (Weidner et al., 1996) . It should be noted, though, that ectopic expression of this construct may interfere with any other signaling molecule(s) that would bind to the Gab1-binding site in Met. A Gab1-mutant in which all YDXP-consensus sites for Crk ± SH2 binding have been mutated still interacts with Crk ± SH2 in yeast two-hybrid screen (data not shown), suggesting that Crk ± SH2-binding region(s) not conforming to the consensus recognition sequence exists within Gab1. Hence, we have been unable to utilize a mutant form of Gab1 that fails to interact with Crk as a putative dominant ± negative construct to study the eect of this mutant on Met-induced JNK activation. We can not therefore rule out the possibility that another potential Crk-binding protein downstream of Met stimulation might also contribute to Met-induced JNK activation.
We have not addressed here the molecular events downstream of the Gab1 ± Crk complex that lead to JNK activation, but we have previously established that Crk-mediated JNK activation takes place via activation of the small GTP-binding protein Rac, which in turn occurs through the Crk SH3-binding proteins, such as C3G, Sos or DOCK180 (Dol® et al., 1998) . Similarly, we have found that a dominantnegative form of Rac (RacN17) eciently blocks both Tpr/Met and HGF/SF-induced JNK activation (data not shown). Importantly, the same dominant ± negative mutant of Rac has been shown to reduce Tpr/Met transformation (Rodrigues et al., 1997) . Taken together, these data suggest a linear pathway from Gab1 ± Crk to Rac activation that ultimately stimulates the JNK kinase and controls biological events downstream of Met.
Despite the importance of oncogenic Met and HGF/SF in inducing metastatic properties on tumors, little is known about the connection between Met and MMP expression. We found here that the lung carcinoma cell line A549 expresses low levels of interstitial collagenase-1 (MMP-1) mRNA (see Giambernardi et al., 1998) and the expression is remarkably increased upon treatment of cells with HGF/SF. In the same manner, transfection of the Tpr/Met oncogene in HeLa cells triggered the expression of MMP-1 mRNA from negligible basal expression levels. These induced levels of MMP-1 mRNA could be explained by either stabilization of the MMP-1 mRNA by Met signaling, or by an enhanced transcription of the MMP-1 gene. Our results using reporter plasmids in which luciferase expression is controlled by sequences of the human MMP-1 promoter suggest that Met activity directly controls the transcription of MMP-1 gene. Also, deletion studies demonstrated that the 5'-proximal AP-1 site in the promoter plays a prominent role in the induction of MMP-1 transcription by Met. Interestingly, cytokines such as IL-1 and TNF-a have been shown to regulate the induction of MMP-1 transcription through this AP-1 site (Lafyatis et al., 1990; Westwick et al., 1994) , and in the case of TNF-a, the JNK pathway was shown to determine the transcriptional activity of the c-Fos/Jun complex on the AP-1 element (Brenner et al., 1989; Westwick et al., 1994) . In concordance with these results, our data suggest that AP-1-mediated transcription of MMP-1 in response to Met is probably controlled by JNK and also by the Gab1 ± Crk complex. Hence, our results demonstrate that Gab1 and Crk control the Metinduced MMP-1 transcriptional activity and JNK activation in a similar manner. We found that expression of Gab1 enhances both JNK activity and MMP-1 transcription by Met, and that the two events in turn are signi®cantly impaired by the ectopic expression of dominant-negative constructs of Crk.
Taken together, our results identify the Gab1 ± Crk signaling complex as a potentially important regulator of the JNK activation downstream of Met and suggest that the complex formation may be functionally important for some of the pleiotropic biological effects of Met, such as cell transformation and metastasis. Importantly, we have found that human Met oncogenes causing renal carcinomas also activate the JNK pathway by mechanisms that involve the formation of the Gab1 ± Crk complex (data not shown). It remains to be determined whether the Gab1 ± Crk interaction regulates other biochemical pathways downstream of Met and what the full functional signi®cance of the Gab1 ± Crk complex in Met signaling is.
Materials and methods

Cell culture and transfections
HeLa, COS-7 and A549 cells were cultured in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% fetal calf serum, penicillin (100 U/ml) and streptomycin (100 mg/ml) (Irvine Scienti®c). Cell transfections were performed using the LipofectAMINE reagent (Life Technologies, Inc.) following the manufacturer's instructions. For HGF/SF stimulation experiments, cells were serum-starved for 18 h and subsequently incubated with the indicated concentrations of HGF/SF (Calbiochem) in DMEM for 15 min at 378C. Transfection eciency was monitored by a contransfection with the plasmid pCMVb-Gal coding for bgalactosidase.
Plasmids and cDNA constructs
The c-CrkII-constructs used in this study have been described in (Matsuda et al., 1992a; Tanaka et al., 1993) . The MAP kinase vectors pCMV5 ± JNK1 ± FLAG and pSRa ± ERK ± HA have been described in (Cavigelli et al., 1995) . pSG-v-Src plasmid has been described in (Minden et al., 1995) . The cDNA encoding the Tpr/Met oncogene was cloned into the mammalian expression vector pcDNA3 (Invitrogen). The mutants Tpr/Met Y482F ± Y489F (Tpr/Met YY) and Tpr/ Met K243A (Tpr/Met KD) were constructed by using PCR techniques and the QuickChange Site-Directed Mutagenesis Kit (Stratagene). The murine Gab1 ± HA cDNA has been described in (Holgado-Madruga et al., 1996) . The Met binding domain of Gab1 (Gab1 ± MBD), as de®ned in (Weidner et al., 1996) , includes an initial methionine residue for mammalian expression. The corresponding cDNA was ampli®ed by PCR and cloned into the pcDNA3 vector. The SH2 domain of Crk (amino acids 1 ± 116) was ampli®ed by PCR and cloned in frame with the LexA sequence to the yeast two-hybrid vector pBTM116 and to a derivative of this vector, pBTM116 ± Src, which additionally codes for the activated mutant form of the tyrosine kinase Src (Keegan and Cooper, 1996) . The domain of Gab1 referred here as the substrate domain (SD) includes residues 220 to 453 and was ampli®ed by PCR and cloned in frame with the VP16 protein into the yeast two-hybrid vector pVP16. The luciferase reporter vectors containing the MMP-1 span the nucleotides 7325 to +1, 773 to +1 and 763 to +1 for MMP ± Luc, MMP-1(773)-Luc and MMP-1(763)-Luc, respectively.
Immunoprecipitation and immunoblotting
Cell monolayers were rinsed with ice-cold phosphate-buered saline (PBS) and lysed on ice for 5 min in lysis buer [ 50 mM HEPES, pH 7.9, 150 mM NaCl, 1 mM EGTA, 10% glycerol, 1 % Triton X-100, 1.5 mM MgCl 2 , 200 mM Na 3 VO 4 , 50 mM NaF, 0.1 U/ml aprotinin, 10 mg/ml leupeptin and 1 mM phenylmethylsulfonyl¯uoride (PMSF)]. Cell lysates were cleared by centrifugation for 15 min at 48C. Samples were normalized for the protein content as determined by the DC protein Assay (Bio-Rad) and subjected to immunoprecipitation with anti-Met (C-28, Santa Cruz Biotechnology, #sc-161), anti-Gab1 (Upstate Biotechnology, #06-579) or antiCrk (Transduction Laboratories, #C12620) antibodies. The immunoprecipitated proteins were analysed by immunoblotting with anti-Crk (Transduction Laboratories, #C12620), anti-Met (ascites from mouse monoclonal hybridoma raised against the C-terminal portion of the human Met, provided by Dr. G. Vande Woude), anti-HA (Y-11, Santa Cruz, #sc-805), anti-FLAG (M2, Kodak, #IB13026) or anti-phosphotyrosine (PY20:HRPO, Transduction Laboratories, #P11625) antibodies. Induction of tyrosine phosphorylation levels of intracellular proteins was monitored as an indication of in vivo v-Src activity in v-Src transfected cells. Immunoreactive bands were detected with horseradish peroxidaseconjugated anti-mouse IgG or protein A (Sigma) and enhanced chemiluminescence (SuperSignal Chemiluminiscent Substrate, Pierce). For re-immunoprecipitation experiments using the anti-Gab1 antibody, the protein complexes were eluted from the beads in 2% SDS, 150 mM NaCl (958C), diluted to a ®nal concentration of 0.1% SDS using lysis buer and immunoprecipitated with the anti-Gab1 antibody.
In vitro MAP kinase assays and luciferase reporter assays
In vitro MAP kinase assays were performed as previously described (Cavigelli et al., 1995) . HeLa cells were transiently transfected and serum starved for 18 h prior to preparing protein lysates in ice-cold kinase lysis buer (50 mM HEPES, pH 7.6, 250 mM NaCl, 3 mM EGTA, 3 mM EDTA, 100 mM Na 3 VO 4 , 0.5% NP-40, 10 mg/ml leupeptin, 10 U/ml aprotinin, and 1 mM PMSF). In some experiments, the cells were stimulated with HGF/SF for 15 min at 378C prior to the kinase assays. Lysates containing equal amounts of total protein were subjected to immunoprecipitations with anti-FLAG(M2) or anti-HA antibodies and protein A-Sepharose. Following immunoprecipitations, the precipitates were dried and stored at 7208C overnight. The beads were then washed with kinase assay buer (50 mM HEPES, pH 7.6, 10 mM MgCl 2 ) and immune complex kinase assays were performed in a ®nal volume of 20 ml containing the beads, 10 mM ATP, 1 mCi [g-32P]ATP and either 5 mg of GST ± cJun(1 ± 79) (Stratagene) or 5 mg of myelin basic protein (Sigma) as substrates for JNK or ERK, respectively. After incubation at 308C for 20 min, SDS ± PAGE sample buer was added and the mixture heated at 958C for 5 min prior SDS ± PAGE and visualization by autoradiography. The incorporation of 32P ± ATP for each kinase reaction was evaluated using a phosphorimager system (Bio-Rad, GS-525) and displayed as values normalized to non-stimulated control samples. In parallel with the kinase assays, equal aliquots of the protein lysates were analysed with the antibodies indicated in the ®gure legends to determine the expression levels of the transfected or endogenous proteins. The amount of immunoprecipitated ERK and JNK was con®rmed by subjecting 1/10 of the corresponding immunoprecipitates to immunoblotting with antiepitope antibodies. For luciferase assays, HeLa cells were cotransfected with 1 mg of the pFR ± Luc reporter plasmid, 50 ng of pFA-c-Jun (91 ± 223) (Stratagene, PathDetect Reporting System) and with the plasmids indicated in the ®gure legends. After transfection, the cells were serum-starved for 18 h, lysed and analysed for luciferase activity using the Luciferase Assay System (Promega) according to manufacturer's protocol. The experiments were performed in triplicate and the data shown are median values with standard deviation.
Yeast-two hybrid interactions
The yeast two-hybrid interaction analysis was performed essentially as described in (Vojtek et al., 1997) using the L40 yeast strain. The yeast were transformed with the plasmids indicated in the ®gure legends and positive protein ± protein interactions determined by histidine prototrophy selection and b-galactosidase activity. The yeast two-hybrid protein ± protein interactions were also evaluated by quantifying the b-galactosidase activity in liquid cultures using o-nitrophenylb-galactopyranoside (Sigma) as the substrate.
PCR analysis of MMP-1 expression
Total RNA was isolated from cell cultures using the RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. cDNA synthesis was performed using the Superscript Preampli®cation system (Gibco BRL). Independent reactions containing 5 mg total RNA each were primed with oligo-dT or random hexamers, combined and analysed by PCR using Ready To Go PCR beads (Pharmacia). The cDNA concentrations in samples from stimulated or unstimulated cells were normalized for expression of the b-actin gene using gene speci®c oligonucleotides (forward: 5'-CCA AGG GCC AAC CGC GAGAAG ATG AC-3' and reverse: 5-AGG GTA CAT GGT GCC GCC AGA C-3'). Ampli®cations were performed under the following PCR conditions: 948C for 5 min, followed by 20 ± 30 cycles at 948C for 30 sec, 588C for 30 sec and 728C for 1 min. Normalized cDNAs were analysed for MMP-1 expression using the following oligonucleotides: forward, 5'-AAG TGA AAA GCG GAG AAA TAG TGG-3' and reverse, 5'-TAG AAT GGG AGA GTC CAA GAG AAT G-3'. The size of the PCR product was 529 bp. The ampli®cation pro®le was 948C for 5 min, followed by 30 ± 45 cycles at 948C for 30 sec, 608C for 30 sec and 728C for 1 min. PCR reactions were resolved on 2% agarose gel and visualized by ethidium bromide staining. The identify of the MMP-1 PCR products was con®rmed by restriction mapping.
